#$%^&*AU2015201280A120150402.pdf#####ABSTRACT The present invention provides novel anti-cytomegalovirus antibodies recognizing the neutralizing epitope AD2-S 1 of gB and related compositions and methods. These antibodies may be used in the diagnosis, prevention, and treatment of cytomegalovirus infection.3/16 HCMV VIRAL ELISA 3.503.00-2.50-- I= tc88 pep 1.000.500,0010 10010,0 mnAb (ng/rnI) HCMV VIRAL ELISA 3.503.00-2.50-n2.00- ..... . CMVp < 1.50- ltc88 1,000,500,00t ---0 10 1000 100000 mnAb (ng/rnI)